Baku

As an emerging hub at the crossroads of Europe and Asia, the Baku life sciences ecosystem is undergoing a rapid transformation driven by strategic government investment and healthcare modernization.

Baku is best known for its role as a regional leader in pharmaceutical distribution and supply chain excellence, with major players like Zeytun Pharmaceuticals and Azeri Med ensuring the delivery of high-quality medicines across the Caucasus.

The city’s healthcare innovation landscape is anchored by the full implementation of compulsory health insurance, which has catalyzed a significant surge in demand for advanced medical devices and digital health solutions.

In the biotechnology and academic research sectors, institutions like Khazar University and the Azerbaijan Medical University are spearheading studies in molecular biology and biomedical engineering, focusing on hereditary diseases and oxidative stress biomarkers.

The annual Medinex exposition serves as the premier platform for global stakeholders to engage with the local market, showcasing the latest in medical technology and diagnostic equipment.

With a growing emphasis on clinical trial activity and the integration of AI in healthcare, Baku is positioning itself as an attractive destination for foreign direct investment.

Furthermore, the development of specialized industrial zones is streamlining the manufacturing of pharmaceutical products and vaccines to reduce import dependency.

This dynamic environment, supported by international quality certifications like GDP and ISO standards, makes Baku a vital link for companies seeking to expand their footprint in the CIS region’s biopharmaceutical and life sciences markets.